OA13042A - Process for preparing a polymorph of rosiglitazonemaleate. - Google Patents

Process for preparing a polymorph of rosiglitazonemaleate. Download PDF

Info

Publication number
OA13042A
OA13042A OA1200500267A OA1200500267A OA13042A OA 13042 A OA13042 A OA 13042A OA 1200500267 A OA1200500267 A OA 1200500267A OA 1200500267 A OA1200500267 A OA 1200500267A OA 13042 A OA13042 A OA 13042A
Authority
OA
OAPI
Prior art keywords
compound
solvent
maleate
mixture
preparing
Prior art date
Application number
OA1200500267A
Other languages
English (en)
Inventor
Andrew Simon Craig
Robert Gordon Giles
Tim Chien Ting Ho
Michael John Sasse
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of OA13042A publication Critical patent/OA13042A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200500267A 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazonemaleate. OA13042A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process

Publications (1)

Publication Number Publication Date
OA13042A true OA13042A (en) 2006-11-10

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200500267A OA13042A (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazonemaleate.

Country Status (18)

Country Link
US (1) US20070167494A1 (ja)
EP (1) EP1615918A1 (ja)
JP (1) JP2006521340A (ja)
KR (1) KR20050120670A (ja)
CN (1) CN1768057A (ja)
AU (2) AU2004224068A1 (ja)
BR (1) BRPI0408752A (ja)
CA (1) CA2520249A1 (ja)
EA (1) EA009331B1 (ja)
EC (1) ECSP056038A (ja)
GB (1) GB0307259D0 (ja)
IS (1) IS8087A (ja)
MA (1) MA27727A1 (ja)
MX (1) MXPA05010413A (ja)
NO (1) NO20054911L (ja)
OA (1) OA13042A (ja)
WO (1) WO2004085435A1 (ja)
ZA (1) ZA200507100B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
MX2020003462A (es) 2017-01-27 2020-08-03 Neurocrine Biosciences Inc Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).
MX2020002841A (es) 2017-09-21 2020-07-22 Neurocrine Biosciences Inc Formulacion de valbenazina de alta dosis y composiciones, metodos y kits relacionados con la misma.
KR20200066661A (ko) 2017-10-10 2020-06-10 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 vmat2 억제제의 투여 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
OA11871A (en) * 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
PE20010045A1 (es) * 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona
EP1322647A1 (en) * 2000-09-26 2003-07-02 Dr. Reddy's Research Foundation Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation

Also Published As

Publication number Publication date
AU2008237610A1 (en) 2008-11-27
AU2004224068A1 (en) 2004-10-07
EA009331B1 (ru) 2007-12-28
US20070167494A1 (en) 2007-07-19
IS8087A (is) 2005-10-24
WO2004085435A1 (en) 2004-10-07
EA200501527A1 (ru) 2006-02-24
ECSP056038A (es) 2006-01-27
KR20050120670A (ko) 2005-12-22
ZA200507100B (en) 2006-07-26
CN1768057A (zh) 2006-05-03
BRPI0408752A (pt) 2006-03-28
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
NO20054911L (no) 2005-10-24
JP2006521340A (ja) 2006-09-21
GB0307259D0 (en) 2003-05-07
MXPA05010413A (es) 2005-11-04
EP1615918A1 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
US7655798B2 (en) Process of making crystalline Type II aripiprazole
US7538213B2 (en) Methods for preparation of olanzapine polymorphic form I
FR2900655A1 (fr) Forme alpha du mesylate d'imatinib et procede de production de celui-ci
AU2008237610A1 (en) Process for preparing a polymorph of rosiglitazone maleate
JPH04507085A (ja) 置換イソフラボン誘導体の改良された製造方法
JP2008094848A (ja) 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩
WO2007109799A2 (en) Polymorphs of eszopiclone malate
WO2008084494A1 (en) Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same
US20050065168A1 (en) Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
AU2009336561A1 (en) Stable R-(+)-lansoprazole amine salt and a process for preparing the same
EP1858855B2 (en) Process of making crystalline type ii aripiprazole
EP2197273B1 (en) Process for preparing r-gossypol l-phenylalaninol dienamine
EP2242758B1 (en) Crystalline form of abacavir that is essentially free of solvent
KR102131107B1 (ko) 3-아미노-피페리딘 화합물의 신규한 제조 방법
KR101125123B1 (ko) 높은 광학적 순도의 ｓ-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물
EP0531078B1 (en) (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form
KR20070088750A (ko) 무수 아리피프라졸 제ｉｉ형의 제조 방법
US20060217408A1 (en) Preparation of cabergoline
JP4205130B2 (ja) トレミフェン結晶化法
KR20220127965A (ko) 리나글립틴의 안정한 결정형 b의 제조방법
JP2004530725A (ja) フェニルエタノールアミンの結晶形、その製造、およびそれを含む医薬組成物
EP1140841A1 (fr) Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation
EP2109613A2 (en) Polymorphs of eszopiclone malate